tiprankstipranks
Trending News
More News >
Viking Therapeutics (DE:1VT)
FRANKFURT:1VT

Compare Viking Therapeutics (1VT) vs. Competitors

Compare
75 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Viking Therapeutics
€28.85
€3.25B
-6.36
6.03%
12 Buy
0 Hold
0 Sell
Strong Buy
Ultragenyx Pharmaceutical
$20.27
$1.96B
-3.94
-48.26%
20 Buy
1 Hold
0 Sell
Strong Buy
Xenon
$54.42
$4.53B
-10.27
53.99%
19 Buy
0 Hold
0 Sell
Strong Buy
Scholar Rock Holding
$43.66
$5.02B
-13.37
32.10%
13 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$24.38
$4.96B
-10.43
24.13%
8 Buy
2 Hold
0 Sell
Strong Buy
NewAmsterdam Pharma Company
$30.01
$3.45B
-19.69
25.72%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:1VT
Viking Therapeutics
28.85
1.95
7.25%
RARE
Ultragenyx Pharmaceutical
20.27
-19.09
-48.50%
XENE
Xenon
54.42
17.97
49.30%
SRRK
Scholar Rock Holding
43.66
9.85
29.13%
IMVT
Immunovant
24.38
4.94
25.41%
NAMS
NewAmsterdam Pharma Company
30.01
6.01
25.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts